Artificial Intelligence is revolutionising drug discovery, allowing us to develop better medicines faster. Research at Queen Mary includes the development of generative models for drug discovery in skeletal and cardiac muscle disease, deep learning-based methods for the prediction of peptide-receptor interactions, machine learning and druggability prediction for target prioritisation, and transfer learning for drug discovery. Queen Mary hosts the AI for Drug Discover Doctoral Training Programme funded by the BBSRC.
Examples of QM staff working in this field:
Research Centres: Centre for Chemical Research; Centre for Molecular Cell Biology